Skip to main content

cancer Archives

Lung cancer survival signal

Nov. 30, 2018—New research by Jonathan Lehman and Pierre Massion have identfied a bioimarker that suggests poor prognosis for small-cell lung cancer, as well as potential target for new therapies.

Read more


Vanderbilt study suggests way to prevent rare lung disease

Nov. 15, 2018—Pulmonary hypertension may be treated by targeting a bone marrow cell that normally promotes the growth of new blood vessels, according to new research by David Merryman.

Read more


Mary Kay Foundation grant to bolster immunotherapy research

Oct. 26, 2018—The grant will allow Charles Caskey to lead research into using ultrasound as an image-guided therapy for drug delivery.

Read more


Grant enhances study of new chemotherapy targets

Oct. 19, 2018—Vanderbilt chemists have been awarded $7.2 million over the next five years from the National Cancer Institute to lead an initiative to better understand how a combination chemotherapy for breast cancer targets DNA.

Read more


Team’s potential lung cancer therapy lands award from SBIR

Sep. 27, 2018—A potential cancer drug aimed at enhancing the effectiveness of ionizing radiation in lung cancer patients is a step closer to development with funding support from the Small Business Innovation Research program.

Read more


Cancer Moonshot award to help map tumor progression

Sep. 27, 2018—A trans-institutional team of researchers at Vanderbilt University Medical Center and Vanderbilt University has received an $11 million Cancer Moonshot grant to build a single-cell resolution atlas to map out the routes that benign colonic polyps take to progress to colorectal cancer, the third most common cancer among both men and women in the United States.

Read more


Limited submission opportunity: 2019 Rita Allen Foundation Scholars Award

Jun. 28, 2018—Vanderbilt (VU and VUMC collaboratively) may nominate one candidate for the Rita Allen Foundation Scholars Award Program for 2019. The foundation supports early-career biomedical scholars doing pioneering research. This award typically provides $550,000 over five yearsfor young investigators involved in research in the cure and treatment of diseases in the fields of cancer, immunology, and neuroscience.

Read more


Karijolich named 2018 Pew Biomedical Scholar

Jun. 14, 2018—John Karijolich, PhD, assistant professor of Pathology, Microbiology, and Immunology at Vanderbilt University Medical Center, has been named a Pew Biomedical Scholar by The Pew Charitable Trusts.

Read more


$8.1 million grant funds new center to research highly aggressive form of lung cancer

Jun. 8, 2018—A five-year National Cancer Institute grant will fund an interdisciplinary research center for the study of small cell lung cancer, a highly aggressive, incurable form of the disease.

Read more


VUMC researchers find a way to ‘starve’ cancer

Jan. 16, 2018—Researchers at Vanderbilt University Medical Center (VUMC) have demonstrated for the first time that it is possible to starve a tumor and stop its growth with a newly discovered small compound that blocks uptake of the vital nutrient glutamine.

Read more


Radiation and pulmonary fibrosis

Nov. 15, 2017—To develop strategies for preventing radiation-induced lung fibrosis (scarring), Vanderbilt investigators are exploring the cell types and factors that contribute to the fibrotic response.

Read more


Boosting sarcoma cell death

Oct. 4, 2017—A compound identified at Vanderbilt represents a new lead for treating rare, aggressive childhood cancers called Ewing sarcomas.

Read more


Upcoming Events

MORE EVENTS »